321 related articles for article (PubMed ID: 23954168)
1. Is CD69 an effective brake to control inflammatory diseases?
González-Amaro R; Cortés JR; Sánchez-Madrid F; Martín P
Trends Mol Med; 2013 Oct; 19(10):625-32. PubMed ID: 23954168
[TBL] [Abstract][Full Text] [Related]
2. The pivotal role of CD69 in autoimmunity.
Gorabi AM; Hajighasemi S; Kiaie N; Gheibi Hayat SM; Jamialahmadi T; Johnston TP; Sahebkar A
J Autoimmun; 2020 Jul; 111():102453. PubMed ID: 32291138
[TBL] [Abstract][Full Text] [Related]
3. CD69: an unexpected regulator of TH17 cell-driven inflammatory responses.
Martín P; Sánchez-Madrid F
Sci Signal; 2011 Mar; 4(165):pe14. PubMed ID: 21427408
[TBL] [Abstract][Full Text] [Related]
4. Oxidized Low-Density Lipoprotein Receptor in Lymphocytes Prevents Atherosclerosis and Predicts Subclinical Disease.
Tsilingiri K; de la Fuente H; Relaño M; Sánchez-Díaz R; Rodríguez C; Crespo J; Sánchez-Cabo F; Dopazo A; Alonso-Lebrero JL; Vara A; Vázquez J; Casasnovas JM; Alfonso F; Ibáñez B; Fuster V; Martínez-González J; Martín P; Sánchez-Madrid F
Circulation; 2019 Jan; 139(2):243-255. PubMed ID: 30586697
[TBL] [Abstract][Full Text] [Related]
5. CD69 association with Jak3/Stat5 proteins regulates Th17 cell differentiation.
Martín P; Gómez M; Lamana A; Cruz-Adalia A; Ramírez-Huesca M; Ursa MA; Yáñez-Mo M; Sánchez-Madrid F
Mol Cell Biol; 2010 Oct; 30(20):4877-89. PubMed ID: 20696842
[TBL] [Abstract][Full Text] [Related]
6. Crucial role for CD69 in allergic inflammatory responses: CD69-Myl9 system in the pathogenesis of airway inflammation.
Kimura MY; Hayashizaki K; Tokoyoda K; Takamura S; Motohashi S; Nakayama T
Immunol Rev; 2017 Jul; 278(1):87-100. PubMed ID: 28658550
[TBL] [Abstract][Full Text] [Related]
7. CD69: from activation marker to metabolic gatekeeper.
Cibrián D; Sánchez-Madrid F
Eur J Immunol; 2017 Jun; 47(6):946-953. PubMed ID: 28475283
[TBL] [Abstract][Full Text] [Related]
8. Patients with Systemic Lupus Erythematosus Show Increased Levels and Defective Function of CD69
Vitales-Noyola M; Oceguera-Maldonado B; Niño-Moreno P; Baltazar-Benítez N; Baranda L; Layseca-Espinosa E; Abud-Mendoza C; González-Amaro R
Mediators Inflamm; 2017; 2017():2513829. PubMed ID: 29038617
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells promote the sustained expression of CD69 on activated T lymphocytes: roles of canonical and non-canonical NF-κB signalling.
Saldanha-Araujo F; Haddad R; Farias KC; Souza Ade P; Palma PV; Araujo AG; Orellana MD; Voltarelli JC; Covas DT; Zago MA; Panepucci RA
J Cell Mol Med; 2012 Jun; 16(6):1232-44. PubMed ID: 21777379
[TBL] [Abstract][Full Text] [Related]
10. CD69 is the crucial regulator of intestinal inflammation: a new target molecule for IBD treatment?
Radulovic K; Niess JH
J Immunol Res; 2015; 2015():497056. PubMed ID: 25759842
[TBL] [Abstract][Full Text] [Related]
11. A new therapeutic target: the CD69-Myl9 system in immune responses.
Kimura MY; Koyama-Nasu R; Yagi R; Nakayama T
Semin Immunopathol; 2019 May; 41(3):349-358. PubMed ID: 30953160
[TBL] [Abstract][Full Text] [Related]
12. Non-traditional CD4+CD25-CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation.
Zhao XS; Wang XH; Zhao XY; Chang YJ; Xu LP; Zhang XH; Huang XJ
J Transl Med; 2014 Jul; 12():187. PubMed ID: 24984576
[TBL] [Abstract][Full Text] [Related]
13. Glycosylation-dependent interaction between CD69 and S100A8/S100A9 complex is required for regulatory T-cell differentiation.
Lin CR; Wei TY; Tsai HY; Wu YT; Wu PY; Chen ST
FASEB J; 2015 Dec; 29(12):5006-17. PubMed ID: 26296369
[TBL] [Abstract][Full Text] [Related]
14. CD4+ T cells in inflammatory diseases: pathogenic T-helper cells and the CD69-Myl9 system.
Nakayama T; Hirahara K; Kimura MY; Iwamura C; Kiuchi M; Kokubo K; Onodera A; Hashimoto K; Motohashi S
Int Immunol; 2021 Nov; 33(12):699-704. PubMed ID: 34427648
[TBL] [Abstract][Full Text] [Related]
15. T helper cells plasticity in inflammation.
Cosmi L; Maggi L; Santarlasci V; Liotta F; Annunziato F
Cytometry A; 2014 Jan; 85(1):36-42. PubMed ID: 24009159
[TBL] [Abstract][Full Text] [Related]
16. CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential.
Radulovic K; Manta C; Rossini V; Holzmann K; Kestler HA; Wegenka UM; Nakayama T; Niess JH
J Immunol; 2012 Feb; 188(4):2001-13. PubMed ID: 22250092
[TBL] [Abstract][Full Text] [Related]
17. Inflammation-induced CD69
Zhang X; Jiang Z; Gu Y; Liu Y; Cao X; Han Y
Sci China Life Sci; 2016 Dec; 59(12):1259-1269. PubMed ID: 27933593
[TBL] [Abstract][Full Text] [Related]
18. CD69 limits the severity of cardiomyopathy after autoimmune myocarditis.
Cruz-Adalia A; Jiménez-Borreguero LJ; Ramírez-Huesca M; Chico-Calero I; Barreiro O; López-Conesa E; Fresno M; Sánchez-Madrid F; Martín P
Circulation; 2010 Oct; 122(14):1396-404. PubMed ID: 20855659
[TBL] [Abstract][Full Text] [Related]
19. Higher Sensitivity of Foxp3+ Treg Compared to Foxp3- Conventional T Cells to TCR-Independent Signals for CD69 Induction.
Bremser A; Brack M; Izcue A
PLoS One; 2015; 10(9):e0137393. PubMed ID: 26352149
[TBL] [Abstract][Full Text] [Related]
20. [Expression kinetics of CD69 molecule by CD3⁺ lymphocytes and γδT cells under three different activating modalities].
Wang K; Hou Y; Wang X; Han G
Zhonghua Xue Ye Xue Za Zhi; 2014 Aug; 35(8):753-4. PubMed ID: 25152129
[No Abstract] [Full Text] [Related]
[Next] [New Search]
